News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Caprion Pharmaceuticals Announces Completion Of Phase I Clinical Studies For Its Shigatoxin-Producing E. coli Therapy


9/20/2006 11:08:30 AM

MONTREAL--(BUSINESS WIRE)--Sept. 19, 2006--Caprion Pharmaceuticals Inc. announced today the completion of Phase I studies for Shigamabs(R), its therapeutic product currently in human clinical trials for the treatment of Shigatoxin-producing E. coli infections.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES